Table 3.
Multivariate analysis for primary and secondary outcomes between the ESRD and non-ESRD cohorts.
| Categorical outcomes |
||||||
|---|---|---|---|---|---|---|
| No ESRD | ESRD | p-value | OR ( 95 % CI ) | p-value | ||
| N = 8073 | N = 730 | |||||
| ICU mortality, N (%) | 1472 (18.50) | 214 (29.52) | <.0001 | 1.26 (1.03 ; 1.53) | .02 | |
| Hospital mortality, N (%) | 2560 (31.78) | 358 (49.04) | <.0001 | 1.44 (1.21 ; 1.72) | <.0001 | |
| Continuous outcomes among hospital survivors | ||||||
| ICU length of stay, (LOS) (Median, IQR) | 4.25 (8.95) | 6.19 (11.60) | .015 | 2.04 (0.31 ; 3.76) | .02 | |
| Hospital length of stay, (LOS) (Median, IQR) | 23.00 (38.00) | 28.00 (42.00) | .005 | 10.08 (3.87 ; 16.28) | .002 | |
| Mechanical ventilation duration, (Median, IQR) | 2.00 (8.00) | 3.00 (10.00) | .03 | 6.98 (0.41; 13.55) | .037 | |
The following variables were included in the model; Age; Gender; Admission category; Diabetes; Chronic cardiac disease; Chronic liver disease; Chronic respiratory disease; International normalised ratio(INR); Acute Physiology and Chronic Health Evaluation II(APACHE II); lactic acid; vasopressor use; mechanical ventilation.